We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
-13.51%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.42B
AUM Growth
-$216M
Cap. Flow
+$22.7M
Cap. Flow %
1.6%
Top 10 Hldgs %
37.76%
Holding
168
New
6
Increased
60
Reduced
33
Closed
16

Top Buys

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$8.8M
2
AKAM icon
Akamai
AKAM
+$8.14M
3
CI icon
Cigna
CI
+$7.3M
4
AAPL icon
Apple
AAPL
+$6.87M
5
STT icon
State Street
STT
+$5.27M

Sector Composition

Rank Sector Weight
1 Technology 36.94%
2 Financials 15.07%
3 Communication Services 14.95%
4 Healthcare 14.72%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
76
Charles River Laboratories
CRL
$10.9B
$2.54M 0.18%
22,430
EG icon
77
Everest Group
EG
$15.2B
$2.31M 0.16%
10,600
-8,295
-44% -$1.81M
IBOC icon
78
International Bancshares
IBOC
$4.77B
$2.29M 0.16%
66,500
+6,480
+11% +$249K
CVS icon
79
CVS Health
CVS
$137B
$2.28M 0.16%
34,826
+14,526
+72% +$1.08M
MDT icon
80
Medtronic
MDT
$107B
$2.07M 0.15%
22,796
+11,600
+104% +$1.08M
DGX icon
81
Quest Diagnostics
DGX
$25.1B
$2.06M 0.15%
24,700
SNY icon
82
Sanofi
SNY
$104B
$2M 0.14%
46,160
-72,760
-61% -$3.21M
BIDU icon
83
Baidu
BIDU
$35.8B
$1.97M 0.14%
12,435
+4,285
+53% +$799K
FFIV icon
84
F5
FFIV
$22.1B
$1.88M 0.13%
11,625
-1,270
-10% -$218K
VVX icon
85
V2X
VVX
$2.62B
$1.88M 0.13%
86,925
-2,171
-2% -$55.5K
ILMN icon
86
Illumina
ILMN
$29.4B
$1.81M 0.13%
6,204
JPM icon
87
JPMorgan Chase
JPM
$939B
$1.77M 0.12%
18,150
VTRS icon
88
Viatris
VTRS
$20.1B
$1.54M 0.11%
56,100
+21,300
+61% +$690K
FTNT icon
89
Fortinet
FTNT
$112B
$1.3M 0.09%
92,200
GSBC icon
90
Great Southern Bancorp
GSBC
$863M
$1.29M 0.09%
28,010
CRUS icon
91
Cirrus Logic
CRUS
$6.74B
$1.26M 0.09%
37,915
-515
-1% -$19.1K
V icon
92
Visa
V
$677B
$1.25M 0.09%
9,502
ENDP
93
DELISTED
Endo International plc
ENDP
$1.24M 0.09%
169,570
AGN
94
DELISTED
Allergan plc
AGN
$1.14M 0.08%
+8,500
New +$1.39M
PANW icon
95
Palo Alto Networks
PANW
$264B
$1.11M 0.08%
35,400
SIMO icon
96
Silicon Motion
SIMO
$9.19B
$1.07M 0.08%
31,035
+10,095
+48% +$395K
NVO
97
Novo Nordisk
NVO
$216B
$1M 0.07%
43,560
+3,000
+7% +$66.7K
UI icon
98
Ubiquiti
UI
$31.8B
$998K 0.07%
10,035
LRCX icon
99
Lam Research
LRCX
$382B
$981K 0.07%
72,050
SYK icon
100
Stryker
SYK
$127B
$950K 0.07%
6,060

Similar funds

Oak Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Oak Associates held 168 positions worth $1.42B, down 13% from $1.64B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Oak Associates's Q4 2018 filing shows 6 new, 60 increased, 33 reduced and 16 closed positions. Its largest new stake was Akamai: 122,370 shares worth $7.47M. The largest sale was CA, Inc., an estimated $19.6M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 37% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q4 2018 buy was Akamai: 122,370 shares worth $7.47M.
  • Oak Associates added most to Citrix Systems Inc in Q4 2018, an estimated $8.8M increase.
  • Oak Associates's biggest Q4 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $3.69M.
  • Oak Associates fully exited CA, Inc. in Q4 2018, selling an estimated $19.6M.
  • Oak Associates's ten largest holdings make up 38% of its $1.42B portfolio in Q4 2018.
  • Oak Associates opened 6 new positions and closed 16 in Q4 2018.
  • Oak Associates's portfolio value fell 13% quarter-over-quarter to $1.42B.

Based on Oak Associates's 13F filing for Q4 2018, filed 7 Feb 2019.